In patients with type 2 diabetes, the risk for chronic kidney disease differed among users of SGLT2 inhibitors, GLP-1 receptor agonists, DPP-4 inhibitors, and sulfonylurea.

TYPE 2 diabetes (T2D) and hypertension (HTN) are significant contributors to the development of chronic kidney disease (CKD). Both conditions have been linked to glomerulomegaly and podocyte loss, ...

Researchers have identified type 5 collagen as a key factor in kidney fibrosis, revealing its potential as a biomarker to predict chronic kidney disease progression. A repurposed anti-cancer drug, ...

Two significant programs that invested in research on diabetes, dementia, obesity and kidney disease have ended since the ...

That type 2 diabetes diagnosis ... connection between diabetes and cancer that’s sending shockwaves through the medical ...

Trial confirms that oral semaglutide lowers cardiovascular risk in type 2 diabetes, regardless of SGLT2i use. Read more!

What are the risk factors for kidney disease? My mother died from kidney failure a few years ago at age 75 but didn’t even ...

In the SOUL trial, Rybelsus produced a 14% risk reduction of major adverse cardiovascular events in patients with type 2 ...

Frequent consumption of bubbly and sugary drinks could be a contributing factor for any number of reasons that damage kidney ...

Both the injectable and oral forms of semaglutide, a glucagon-like peptide-1 receptor agonist, have gained recent attention ...

Both the injectable and oral forms of semaglutide, a glucagon-like peptide-1 receptor agonist, have gained recent attention ...

Both the injectable and oral forms of semaglutide, a glucagon-like peptide-1 receptor agonist, have gained recent attention ...